Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Sales | 763 | 692 | N/A | 1,918 | 2,359 |
| Gross Profit | 763 | 692 | N/A | 1,918 | 2,359 |
| Operating Expenses | 5,862 | 5,876 | 6,105 | 5,984 | 6,076 |
| Operating Income | -5,099 | -5,183 | -6,105 | -4,066 | -3,718 |
| Other Income | 141 | 134 | 786 | 162 | 113 |
| Pre-tax Income | -4,958 | -5,050 | -5,319 | -3,905 | -3,605 |
| Income Tax | -1,966 | -1,792 | -1,879 | 0 | 0 |
| Net Income Continuous | -2,991 | -3,258 | -3,440 | -3,905 | -3,605 |
| Net Income | $-2,991 | $-3,258 | $-3,440 | $-3,905 | $-3,605 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.06 | -0.07 | -0.09 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.06 | -0.07 | -0.09 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.06 | -0.07 | -0.09 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.06 | -0.07 | -0.09 |
| EBITDA(a) | $-4,887 | $-4,969 | $-5,830 | $-3,870 | $-3,563 |